ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,006Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 189

$600K Total Retail Price of All Prescriptions

Rank: 11 out of 189

666 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 666 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 666 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 9,037 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 722 547 1 1
HYDROCODONE-ACETAMINOPHEN 681 349 S3 2 11
METOPROLOL TARTRATE 596 486 3 6
SIMVASTATIN 503 443 4 2
LEVOTHYROXINE SODIUM 457 349 5 5
HYDROCHLOROTHIAZIDE 443 313 6 8
OMEPRAZOLE 410 289 7 3
AMLODIPINE BESYLATE 402 349 8 4
METFORMIN HCL 284 193 9 7
ENALAPRIL MALEATE 258 192 10 41
OXYCODONE HCL 248 70 S2 11 40
FUROSEMIDE 241 176 12 10
OXYCODONE-ACETAMINOPHEN 206 46 S2 13 76
CITALOPRAM HBR 187 150 14 15
GABAPENTIN 181 94 15 22
PRAVASTATIN SODIUM 169 143 16 13
GLIPIZIDE 165 136 17 39
IBUPROFEN 154 69 18 34
PROAIR HFA 146 97 19 35
OXYCONTIN 132 13 S2 20 75
ZOLPIDEM TARTRATE 128 115 21 24
GLIPIZIDE ER 123 102 22 52
ATENOLOL 122 86 23 12
SERTRALINE HCL 119 69 24 17
LOSARTAN POTASSIUM 114 103 25 20
FLUTICASONE PROPIONATE 109 48 26 30
AMITRIPTYLINE HCL 105 76 R 27 70
PAROXETINE HCL 103 82 28 46
ADVAIR DISKUS 101 57 29 42
TRAZODONE HCL 93 68 30 16
SPIRIVA 89 76 31 33
RANITIDINE HCL 89 83 31 26
ATORVASTATIN CALCIUM 88 76 33 9
ALENDRONATE SODIUM 88 45 33 18
PANTOPRAZOLE SODIUM 86 66 35 58
GLYBURIDE 84 71 R 36 60
FLUOXETINE HCL 84 67 36 29
ALLOPURINOL 81 62 38 25
METOPROLOL SUCCINATE 79 60 39 19
CLOPIDOGREL 77 66 40 48
ACETAMINOPHEN-CODEINE 76 64 S3 41 86
ALPRAZOLAM 76 53 41 95
GLIMEPIRIDE 73 65 43 71
DIOVAN 69 55 44 51
NEXIUM 67 50 45 62
KLOR-CON M20 66 65 46 80
PLAVIX 64 55 47 74
CRESTOR 62 12 48 31
TAMSULOSIN HCL 62 41 48 28
OXYCODONE HCL-ACETAMINOPHEN 61 22 S2 50 114
MIRTAZAPINE 58 36 51 45
LOVASTATIN 58 33 51 21
TRAMADOL HCL 56 53 53 32
PREDNISONE 55 47 54 38
AMPHETAMINE SALT COMBO 54 0 S2 55 211
DILTIAZEM 24HR ER 53 51 56 68
AZITHROMYCIN 50 36 57 47
WARFARIN SODIUM 50 50 57 14
GLIPIZIDE XL 50 32 57 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.